Morristown, N.J., January 28, 2020 – OmniActive will bring new, exciting insights on the market opportunities of macular carotenoids in conjunction with omega-3s at this year’s GOED Exchange during the speaking session, Omega-3s And… which will take place Wednesday, Feb 5th from 4:00pm – 5:15pm. Brian Appell, Marketing Manager of OmniActive Health Technologies, will discuss the market growth potential coming from the macular carotenoids, their conditionally essential role in the “eye-brain connection” and how they may work synergistically with omega-3s.
The macular carotenoids-lutein and zeaxanthin isomers (RR-zeaxanthin and RS [meso]-zeaxanthin)-are imperative for healthy vision for a lifetime. This makes sense considering the location of their respective areas of deposition are highly specific: lutein is preferentially deposited in the peripheral macula, RR-zeaxanthin in the mid-peripheral macula and RS-zeaxanthin in the center of the macula. There is also compelling science illustrating the importance of macular carotenoids for cognition and mental wellness, such as the recent publication on Lutemax® 2020 and it’s positive effect on BDNF.
“The science supporting the health benefits for both omega-3s and macular carotenoids on their own is solid, but when combined, there may be a synergistic effect that bring unique formulation possibilities,” Appell said. “As the premier global forum to discuss the ‘what’s next?’ in omega-3, the GOED Exchange serves as the perfect platform to bring the emerging opportunities that may come from this combination to fill consumer need gaps and spark new ideas to propel market expansion.”
For more information on Lutemax® 2020 or OmniActive’s many health-focused solutions and services, please contact Sara Zoet at firstname.lastname@example.org. For media opportunities, please contact Becky Wright at email@example.com.